Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Wondering about your retirement target at 40? Discover how to plan ahead for a secure financial future with our expert insights.
24,965 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
XDTE has drawn attention with a striking headline yield from zero-day-to-expiration options. This report examines the...
A bold claim from Jim Cramer has reignited the debate over Disney buying Norwegian Cruise Line. With shipyard bottlen...
A near-$150 million Polymarket contract is roiled as traders question payouts after Strategy disclosed BTC sales. The...
BYD’s Q2 2026 results set a new pace for electric vehicles, with a headline figure of 557,090 BEVs. This shift challe...
A New York Fed tariff study finds most costs fall on U.S. businesses and consumers, prompting Kevin Hassett to demand...
AMD posts a 55% month gain as AI data center demand accelerates, eclipsing Intel’s advance. The move sparks a debate ...
As AI workloads surge, Celestica could play a pivotal role in data-center hardware. This guide breaks down the busine...
Institutional buyers push further into digital assets even as skeptical headlines persist. This report examines wheth...
Measles poses a bigger public health risk than Ebola as the World Cup attracts millions to U.S. host cities. Official...
Owlet's Q4 2025 results reveal a company balancing growth with a path toward profitability. This article disentangles...
As market volatility persists, Roundhill's XDTE and QDTE 0DTE ETFs are drawing attention for Friday yields. This anal...